FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014010542> ?p ?o ?g. }

• W2014010542 endingPage "246" @default.
• W2014010542 startingPage "239" @default.
• W2014010542 abstract "study objective: To evaluate the efficacy and side effects of niacin therapy in dyslipidemic individuals. design: A retrospective analysis of patients' charts. setting: An outpatient referral-based clinic specializing in the treatment of lipid disorders. patients: All patients with dyslipidemia treated by niacin (n = 82) at the Atherosclerosis Detection and Prevention Clinic during 1987 to 1990, including a subgroup of 17 dyslipidemic heart transplant recipients. results: Niacin was well tolerated in 83% of the nontransplant group (n = 65) at an average dose of 2.5 ± 0.9 g/day. Similar beneficial lipoprotein effects were found in the transplant and nontransplant patients. The high-density lipoprotein cholesterol (HDL-C) response to niacin therapy was independent of the baseline HDL-C level. In the transplant group, 11 patients (65%) discontinued treatment, primarily because of hyperglycemia; this was especially prominent in those patients with pretreatment diabetes mellitus. Of the 15 patients using sustained-release niacin, eight cases of hepatitis were recorded, some during therapy with relatively low niacin doses. Several different sustained-release preparations were responsible for this phenomenon, suggesting that the cause was not a contaminant in the preparation. No cases of hepatitis were documented in the 67 patients using regular niacin. One case of hepatitis was recently observed in a patient who switched from one type of regular niacin to another, however, we have data to suggest that the substituted preparation was not an immediate-release niacin. A familial predisposition to hepatitis is suggested by the occurrence of this side effect in identical twin brothers and two sisters. A pharmacy survey disclosed that most pharmacists are unaware of the relationship of sustained-release niacin to hepatitis, have a negative impression of regular niacin, and do not stock this formulation. Finally, we found that in this small sample of patients, niacin used with lovastatin is a particularly effective drug combination and appears to have few side effects beyond those seen with niacin alone. conclusions: Our experience supports the fact that regular niacin is a useful lipid-modifying drug. When used appropriately, patients can usually tolerate adequate doses for prolonged periods and achieve meaningful results. However, this requires a certain amount of physician skill and patient motivation. The use of sustained-release preparations to overcome this problem can lead to harmful consequences and should only be done under strict medical supervision. In our opinion, the availability of sustained-release niacin as a nonprescription drug is unjustified and should be reexamined. Finally, we have observed that reduction of very-lowdensity lipoprotein cholesterol (VLDL-C) with niacin alone leads to an elevation in low-density lipoprotein cholesterol in many patients; this indicates to us that the mechanism whereby niacin lowers VLDL-C and total cholesterol is not solely the result of a decreased synthesis of VLDL-C." @default.
• W2014010542 created "2016-06-24" @default.
• W2014010542 creator A5028220327 @default.
• W2014010542 creator A5037091525 @default.
• W2014010542 creator A5060048292 @default.
• W2014010542 creator A5091617982 @default.
• W2014010542 date "1991-09-01" @default.
• W2014010542 modified "2023-10-14" @default.
• W2014010542 title "Niacin revisited: Clinical observations on an important but underutilized drug" @default.
• W2014010542 cites W13663154 @default.
• W2014010542 cites W1979102029 @default.
• W2014010542 cites W1988759828 @default.
• W2014010542 cites W2016821435 @default.
• W2014010542 cites W2033321161 @default.
• W2014010542 cites W2044397157 @default.
• W2014010542 cites W2053281494 @default.
• W2014010542 cites W2070855777 @default.
• W2014010542 cites W2070999659 @default.
• W2014010542 cites W2078486704 @default.
• W2014010542 cites W2084877799 @default.
• W2014010542 cites W2092903282 @default.
• W2014010542 cites W2094172628 @default.
• W2014010542 cites W2115572248 @default.
• W2014010542 cites W2117179212 @default.
• W2014010542 cites W2324712847 @default.
• W2014010542 cites W2403066849 @default.
• W2014010542 cites W2418611981 @default.
• W2014010542 cites W2725187802 @default.
• W2014010542 cites W4243027211 @default.
• W2014010542 doi "https://doi.org/10.1016/0002-9343(91)90122-e" @default.
• W2014010542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1892143" @default.
• W2014010542 hasPublicationYear "1991" @default.
• W2014010542 type Work @default.
• W2014010542 sameAs 2014010542 @default.
• W2014010542 citedByCount "65" @default.
• W2014010542 countsByYear W20140105422012 @default.
• W2014010542 countsByYear W20140105422013 @default.
• W2014010542 countsByYear W20140105422014 @default.
• W2014010542 countsByYear W20140105422015 @default.
• W2014010542 countsByYear W20140105422016 @default.
• W2014010542 countsByYear W20140105422021 @default.
• W2014010542 countsByYear W20140105422022 @default.
• W2014010542 crossrefType "journal-article" @default.
• W2014010542 hasAuthorship W2014010542A5028220327 @default.
• W2014010542 hasAuthorship W2014010542A5037091525 @default.
• W2014010542 hasAuthorship W2014010542A5060048292 @default.
• W2014010542 hasAuthorship W2014010542A5091617982 @default.
• W2014010542 hasConcept C126322002 @default.
• W2014010542 hasConcept C134018914 @default.
• W2014010542 hasConcept C141071460 @default.
• W2014010542 hasConcept C2776029263 @default.
• W2014010542 hasConcept C2776455275 @default.
• W2014010542 hasConcept C2778096610 @default.
• W2014010542 hasConcept C2780092750 @default.
• W2014010542 hasConcept C511355011 @default.
• W2014010542 hasConcept C555293320 @default.
• W2014010542 hasConcept C71924100 @default.
• W2014010542 hasConcept C90924648 @default.
• W2014010542 hasConceptScore W2014010542C126322002 @default.
• W2014010542 hasConceptScore W2014010542C134018914 @default.
• W2014010542 hasConceptScore W2014010542C141071460 @default.
• W2014010542 hasConceptScore W2014010542C2776029263 @default.
• W2014010542 hasConceptScore W2014010542C2776455275 @default.
• W2014010542 hasConceptScore W2014010542C2778096610 @default.
• W2014010542 hasConceptScore W2014010542C2780092750 @default.
• W2014010542 hasConceptScore W2014010542C511355011 @default.
• W2014010542 hasConceptScore W2014010542C555293320 @default.
• W2014010542 hasConceptScore W2014010542C71924100 @default.
• W2014010542 hasConceptScore W2014010542C90924648 @default.
• W2014010542 hasIssue "3" @default.
• W2014010542 hasLocation W20140105421 @default.
• W2014010542 hasLocation W20140105422 @default.
• W2014010542 hasOpenAccess W2014010542 @default.
• W2014010542 hasPrimaryLocation W20140105421 @default.
• W2014010542 hasRelatedWork W1771158870 @default.
• W2014010542 hasRelatedWork W2000817738 @default.
• W2014010542 hasRelatedWork W2048080850 @default.
• W2014010542 hasRelatedWork W2082230169 @default.
• W2014010542 hasRelatedWork W2082415271 @default.
• W2014010542 hasRelatedWork W2158008220 @default.
• W2014010542 hasRelatedWork W2350815287 @default.
• W2014010542 hasRelatedWork W3112458564 @default.
• W2014010542 hasRelatedWork W4293496213 @default.
• W2014010542 hasRelatedWork W812411445 @default.
• W2014010542 hasVolume "91" @default.
• W2014010542 isParatext "false" @default.
• W2014010542 isRetracted "false" @default.
• W2014010542 magId "2014010542" @default.
• W2014010542 workType "article" @default.